Palisade Bio (PALI) Profit After Tax Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -330.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -330.49% |
| Dec 31, 2025 | -166.12% |
| Sep 30, 2025 | 17.75% |
| Jun 30, 2025 | 31.76% |
| Mar 31, 2025 | 36.77% |
| Dec 31, 2024 | -12.55% |
| Sep 30, 2024 | 3.03% |
| Jun 30, 2024 | -20.25% |
| Mar 31, 2024 | -50.73% |
| Dec 31, 2023 | 20.13% |
| Sep 30, 2023 | 9.90% |
| Jun 30, 2023 | -44.75% |
| Mar 31, 2023 | 44.35% |
| Dec 31, 2022 | -446.69% |
| Sep 30, 2022 | -149.35% |
| Jun 30, 2022 | 92.62% |
| Mar 31, 2022 | -4.34% |
| Dec 31, 2021 | 125.28% |
| Sep 30, 2021 | 538.80% |
| Jun 30, 2021 | -1,615.07% |
| Mar 31, 2021 | -69.04% |
| Dec 31, 2020 | -108.28% |
| Sep 30, 2020 | -4.53% |
| Jun 30, 2020 | -28.82% |
| Mar 31, 2020 | 23.44% |
| Dec 31, 2019 | -536.12% |
| Sep 30, 2019 | 3.67% |
| Jun 30, 2019 | -129.16% |
| Mar 31, 2019 | -45.04% |
| Dec 31, 2018 | 90.34% |
| Sep 30, 2018 | -1,268.10% |
| Jun 30, 2018 | 86.51% |
| Mar 31, 2018 | 71.63% |
| Dec 31, 2017 | 38.55% |
| Sep 30, 2017 | 97.44% |
| Jun 30, 2017 | -20.68% |
| Mar 31, 2017 | -14.55% |
| Dec 31, 2016 | -13.24% |
| Sep 30, 2016 | 7.40% |
| Jun 30, 2016 | 29.29% |
| Mar 31, 2016 | -30.73% |
| Dec 31, 2015 | 13.41% |
| Sep 30, 2015 | -26.54% |
| Jun 30, 2015 | 19.30% |
| Mar 31, 2015 | 14.63% |
| Dec 31, 2014 | -66.60% |
| Sep 30, 2014 | 33.37% |
| Jun 30, 2014 | -7.99% |
| Mar 31, 2014 | -64.87% |
| Dec 31, 2013 | -21.67% |
| Sep 30, 2013 | -159.45% |
| Jun 30, 2013 | -163.07% |
| Mar 31, 2013 | -46.37% |
| Dec 31, 2012 | -6.20% |
| Sep 30, 2012 | 19.75% |
| Jun 30, 2012 | 34.87% |
| Mar 31, 2012 | 20.92% |
| Dec 31, 2011 | 6.66% |
| Sep 30, 2011 | 18.28% |
| Jun 30, 2011 | 26.31% |